Facts
as of Nov 17, 2026
Developing Transformative Cell and Exosome-based Therapeutics. Capricor Therapeutics is a biotechnology company offering a new approach on drug development in Duchenne muscular dystrophy and beyond. We are patient-focused first, while advancing precision medicine.
It is hiring: 11 open roles, 9 of them posted in the last 30 days.
- Legal name
- CAPRICOR THERAPEUTICS, INC.
- Headquarters
- Beverly Hills, United States
- Founded
- 2023
- Employees
- 201-500estimated range
- Listing
- NASDAQ: CAPR
- Open roles
- 11Alion job postings
- Register numbers
- NAME capricor therapeutics inc
- Website
- capricor.com
As of Nov 17, 2026, Alion lists 11 open roles at Capricor Therapeutics, Inc. Capricor Therapeutics, Inc. is headquartered in Beverly Hills, United States. It was founded in 2023. The median pay stated in its open roles is $135k, across 11 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
CAPRICOR THERAPEUTICS, INC.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring at full speed: most open roles are fresh.
Legal is the largest family, 18 of open roles.
9Posted in 30 days82% of open roles are fresh
36%Remote roles4 of 11
1Hiring offices
Can they hire you from United States?by your location
Likely
8 open roles are in your country: you apply locally, no move needed.
United States8On site
Remote, from elsewhere4Rare
No posting offers visa sponsorship. Remote roles: 4.
Alion signals0-100
Demand37
Pay35
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Where the openings areshare of open roles · trend
Legal18▲
Sales18▲
Industrial Engineering18▲
Networking9▲
Analytics9▲
Finance9▲
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
What its postings pay, by level.
$135kMedian
$90k – $310kTypical rangeUSD a year
$318kHighest paying roleSenior Director, Head of Patient Services
Pay by levelmiddle half of stated pay, median marked
Middle3$110k$90k – $110k
Head+5$315k$310k – $318k
$0$88k$175k$263k$350k
Source: the pay stated in the company's postings, normalised to USD a year
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
San DiegoBusiest site
Source: office addresses in postings and company registers
Ranked #7 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)
Financials
1 public grant on record, $1.7M in total.
$1.7MPublic grants1 public grant
Money by yearUSD, rounds and grants
Largest rounds and grants
Sources: funding announcements, grant and company registers
Technologies named in job postings at Capricor Therapeutics, Inc. over the last 12 months, by layer, with the share of postings for each.
24Technologies in use
6Postings analysed
66/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 2%Web presenceof 133.2M domains by links, Common Crawl
Sep 302026
News · Blockonomi
Capricor (CAPR) stock rose after releasing 24-month deramiocel data from its Duchenne trial ahead of the FDA's November 22 decision deadline.
Sep 302026
News · CoinCentral
Capricor Therapeutics (CAPR) stock rose after new Phase 3 data on Duchenne drug deramiocel ahead of a November 22 FDA decision.
Sep 292026
Press release · The Globe and Mail
Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.
Sep 252026
News · NewMediaWire
NEW YORK, NY - September 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (
Sep 242026
News · NewMediaWire
NEW YORK, NY - September 24, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (
Sep 242026
Press release · PRNewswire
/PRNewswire/ -- SueWallSt alerts investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) that a securities class action has been filed on behalf of...
Sources: the outlets named on each headline, each story once